McLean Hospital 115 Mill Street Belmont, MA 02478
Gowri Aragam, MD, is a resident in psychiatry at Massachusetts General Hospital and McLean Hospital. She is also a founding partner and the director of Community and Collaboration for Brainstorm: The Stanford Laboratory for Brain Health Innovation and Entrepreneurship. She completed her medical training at UMass Medical School and her undergraduate education at Harvard College.
Armen C. Arevian, MD, PhD, is the director of the Innovation Lab at the UCLA Semel Institute for Neuroscience and Human Behavior. His work involves “participatory informatics,” combining neuroscience, psychiatry, participatory research, and informatics to support research and health system innovation that is translational and transdiagnostic while seeking to addresses equity and disparities in vulnerable populations. Examples include utilizing speech as a behavioral biomarker in serious mental illness, and Chorus, a web platform that enables individuals without technical expertise (i.e., patients, community leaders) to co-create their own mobile apps based on their needs/priorities, and then use them in real-time.
Justin T. Baker, MD, PhD, is the scientific director of the Institute for Technology in Psychiatry at McLean Hospital. He also serves as director of the Functional Neuroimaging and Bioinformatics for the Schizophrenia and Bipolar Disorder Research Program at McLean, assistant professor of psychiatry at Harvard Medical School, and associate director of the MGH Center for Law, Brain, and Behavior. His work aims to develop efficient strategies to monitor and intervene the course of mental illness..
Ian Barnett, PhD, is an assistant professor of biostatistics at the University of Pennsylvania. His research focuses on the development of statistical methods for the analysis of behavioral smartphone-based digital phenotyping data. His work aims to develop tools capable of identifying the need for interventions in at-risk individuals using their passively collected smartphone sensor data.
Courtney Beard, PhD, is an assistant professor of psychology in the Department of Psychiatry at Harvard Medical School, and at McLean Hospital serves as director of the Cognition and Affect Research and Education (CARE) Laboratory and assistant director of the Behavioral Health Partial Hospital Clinical Research Program.
Alisa Busch, MD, MS, is the chief medical information officer and director of Clinical Performance Measurement & Health Services Research at McLean Hospital, an associate professor of psychiatry at Harvard Medical School, and chief of the Health Services Research Division for Partners Psychiatry and Mental Health. She is a psychiatrist and mental health services researcher who is nationally recognized for her work on measuring mental health care quality in systems of care.
Neha P. Chaudhary, MD, is a chief resident in child and adolescent psychiatry at Massachusetts General Hospital and McLean Hospital and a clinical fellow at Harvard Medical School. She is also a founding partner and the director of Strategy & Design for Brainstorm: The Stanford Laboratory for Brain Health Innovation and Entrepreneurship.
Ken Duckworth, MD, is the medical director for behavioral health at BCBSMA, and an assistant professor of psychiatry at Harvard Medical School. He is the former acting commissioner of mental health for Massachusetts and also was the state medical director. He is the medical director for NAMI, the National Alliance on Mental Illness.
Menachem Fromer, PhD, received his PhD in computer science from the Hebrew University of Jerusalem working on computational protein design, probabilistic graphical models, and machine learning-based optimization. In 2010, he moved to the Broad Institute of MIT and Harvard to work on psychiatric genomics, specifically the analysis of DNA-sequencing of patients with schizophrenia, autism, and controls. He continued this work when he moved to the Icahn School of Medicine at Mount Sinai in NY as an associate professor of psychiatry and genetics, where he also worked on the analysis of RNA-sequencing of postmortem brain samples of patients with schizophrenia. Since 2016, he has worked at Verily on more deeply modeling the phenotypes of neuropsychiatric diseases using digital technologies, such as smartphones and wearable watches, and integrating those with genomic and related data.
Kumar Garg is a senior fellow at the Society for Science and the Public, and a former senior advisor to the deputy director at the White House Office of Science and Technology Policy, focusing on education and broader innovation policy. Kumar Garg helped shape science and technology policy for the Obama administration for nearly eight years. He led the Obama administration’s efforts to bolster science, technology, engineering, and math (STEM) education.
Laura Germine, PhD, is the co-director of the Institute for Technology in Psychiatry at McLean Hospital and a instructor in psychiatry at Harvard Medical School. She is also director of the Laboratory for Brain and Cognitive Health Technology and creator of TestMyBrain.org, a citizen science research initiative.
Satra Ghosh, PhD, is a principal research scientist at the McGovern Institute for Brain Research at MIT, an assistant professor in the Department of Otolaryngology at Harvard Medical School, and a faculty member in the speech and hearing biosciences and technology program in the Harvard Division of Medical Sciences. His research encompasses computer science and neuroimaging, focusing on applied machine learning and translational medicine.
Gary Gottlieb, MD, is CEO of Partners In Health, a provider of healthcare in some of the world’s poorest countries. He previously served as CEO of Partners HealthCare, president of Brigham and Women’s Hospital, Chair of Partners Psychiatry and interim president of McLean Hospital. He is a professor of psychiatry at Harvard Medical School, a member of the National Academy of Medicine, chair of the Federal Reserve Bank of Boston, an executive partner at Flare Capital Partners, and a member of the boards of health tech companies Kyruus and OM1
Oliver Harrison, MD, MPH, is CEO of Alpha Health, Telefonica Alpha’s first Moonshot, which is on a five-year journey to transform health by addressing human behavior. Before Alpha, Oliver held positions at Healthways, the government of Abu Dhabi, and McKinsey’s healthcare practice. Oliver has faculty appointments at both Imperial College and Johns Hopkins University.
Jason Hassenstab, PhD, is the Cognition Core director for the Dominantly-Inherited Alzheimer Network-Trials Unit (DIAN-TU) and the DIAN observational study. He is currently an assistant professor of neurology and of psychological and brain sciences at Washington University in St. Louis, and is the director of neuropsychology for the Knight Alzheimer’s Disease Research Center. His research is focused on assessment approaches for detection of cognitive changes in the earliest stages of Alzheimer’s disease and their relationship to fluid biomarkers and neuroimaging indicators of Alzheimer’s disease pathology. He is also developing remote cognitive assessment paradigms using ecological momentary assessment and measurement burst designs for use in cohort studies and clinical trials. Prior to pursuing academics, Dr. Hassenstab toured internationally as a professional jazz saxophonist and made hundreds of dollars. He completed a bachelor’s degree in Jazz and Contemporary Music Performance from New York University and a PhD in psychology under the mentorship of Dr. Antonio Convit at New York University School of Medicine and Fordham University. He then completed a clinical internship and NIH-sponsored post-doctoral fellowship at Brown University with Drs. Ronald Cohen, Lawrence Sweet, and Steven Salloway. He joined the faculty at Washington University in St. Louis in 2010.
Kristin N. Javaras, DPhil, PhD, is a clinical psychologist and statistician whose research and clinical practice focus on eating disorders and overeating, as well as other commonly co-occurring problems including anxiety and depression. Her research combines psychology, neuroscience, and epidemiology to better understand the development and maintenance of eating- and weight-related disorders and overeating, with the ultimate goal of developing more effective interventions.
Dilip V. Jeste, MD, is a geriatric neuropsychiatrist who specializes in successful aging, neurobiology of wisdom, as well as schizophrenia and other psychotic disorders in older adults. He is the senior associate dean for healthy aging and senior care at the University of California, San Diego (UCSD). He is the director of the Stein Institute for Research on Aging and the Hartford Center for Excellence in Geriatric Psychiatry, as well as the newly launched UC San Diego Center for Healthy Aging, a unique, multi-professional center breaking the traditional silos of academic disciplines by bringing together best scientists from varied professional backgrounds such as engineering, technology, pharmacy, gerontology, social science, arts, and humanities to work collaboratively on different aspects of aging.
Kimberlyn Leary, PhD, MPA, is an associate professor of health policy and management, and program director of Enabling Change at the Harvard T.H. Chan School DrPH Program, an associate professor of psychology in the Department of Psychiatry at Harvard Medical School, executive director of policy outreach at McLean Hospital, a faculty affiliate at the Program on Negotiation at Harvard Law School, and senior advisor to the CEO at the National Math and Science Initiative.
Sarah Lenz Lock, JD, is AARP’s senior vice president for policy, working on the major issues facing older Americans. She also serves as the executive director of the Global Council on Brain Health, an independent collaborative of experts working on brain health related to human cognition. Ms. Lock came to AARP to conduct health care impact litigation on behalf of older persons and has represented the interest of older Americans in appellate courts nationwide. Previously, she served as a legislative assistant in the US House of Representatives and a trial attorney for the US Department of Justice.
Lara Mangravite, PhD, is president of Sage Bionetworks. She develops and implements open community-based research methods to address complex biomedical research problems. These include the use of mobile technology to facilitate remote and frequent exchange of information between scientists and research participants.
Michelle N. Meyer, JD, PhD, is an assistant professor and associate director of research ethics, in the Center for Translational Bioethics and Health Care Policy at Geisinger Health System. She chairs the IRB Leadership Committee, directs the Research Ethics Advice and Consultation Service and sits on the American Psychological Association’s Commission on Ethics Processes, the Board of Directors of Open Humans Foundation, and the Advisory Board of the Social Science Genetic Association Consortium.
Louis-Philippe Morency, PhD, is faculty at the Carnegie Mellon University Language Technology Institute where he leads the Multimodal Communication and Machine Learning Laboratory. His research focuses on building the computational foundations to enable computers with the abilities to analyze, recognize, and predict subtle human communicative behaviors during social interactions.
Susan A. Murphy, PhD, currently at the University of Michigan will be joining Harvard University in September 2017. Her research focuses on improving sequential, individualized, decision making in health, in particular on clinical trial design and data analysis, to inform the development of just-in-time adaptive interventions in mobile health. She is a fellow of the Institute of Mathematical Statistics, a fellow of the College on Problems in Drug Dependence, a former editor of the Annals of Statistics, a member of the US National Academy of Sciences and the US National Academy of Medicine, and a 2013 MacArthur Fellow.
Theresa Nguyen is vice president of policy and program at Mental Health America. She manages MHA Screening which started in 2014, provides 8 anonymous online mental health screens, and to date, has provided more than 2.5 million screens. MHA is identifying how internet-based screening can improve early identification and intervention. As a clinician and advocate, she is exploring how recovery-oriented and consumer-driven supports can be translated into an online space to help improve access to care and reduce the burden of mental illness.
Matthew K. Nock, PhD, is a clinical psychologist and director of the Laboratory for Clinical and Developmental Research at Harvard University whose research focuses on self-harm. He was named a MacArthur Fellow in 2011.
Jukka-Pekka Onnela, PhD, is an associate professor of biostatistics at the Harvard T.H. Chan School of Public Health. His work focuses on statistical network science and digital phenotyping, the quantification of social and behavioral phenotypes from smartphone data.
Scott L. Rauch, MD, is president, psychiatrist in chief, and Rose-Marie and Eijk van Otterloo Chair of Psychiatry at McLean Hospital, a professor of psychiatry at Harvard Medical School, and chair of Partners Psychiatry and Mental Health at Partners HealthCare. He also serves on the Executive Committee of the Institute for Technology in Psychiatry at McLean Hospital.
Kerry J. Ressler, MD, PhD, is the chief scientific officer at McLean Hospital. He also serves on the Executive Committee of the Institute for Technology in Psychiatry, and is chief of the Division of Depression and Anxiety Disorders, James and Patricia Poitras Chair in Psychiatry, and director of the Neurobiology of Fear Laboratory. Dr. Ressler is a professor of psychiatry at Harvard Medical School, and current president of the Society for Biological Psychiatry. He was previously a Howard Hughes Medical Institute investigator and member of the National Academy of Medicine.
John Torous, MD, is a board-certified psychiatrist with a background in electrical engineering and computer science who researches digital mental health, specifically mobile mental health technology. He is the co-director of the digital psychiatry program at Beth Israel Deaconess Medical Center. He chairs the American Psychiatric Association’s smartphone app evaluation workgroup, is editor of the journal JMIR Mental Health, and an advisor to the Precision Medicine Initiative’s mood research efforts.
Laura Tully, PhD, is an assistant professor in psychiatry at UC Davis and director of Clinical Training at the UC Davis Early Psychosis Programs. Dr. Tully received her PhD from Harvard University, completed her post-doc at UC Davis, and transitioned to faculty in 2015. Dr. Tully has expertise in the identification and treatment of young people experiencing psychosis, and the neural and cognitive mechanisms underlying social impairments in psychosis.
Ipsit Vahia, MD, is the medical director of the Institute for Technology in Psychiatry at McLean Hospital, a geriatric psychiatrist, and a member of the faculty at Harvard Medical School. He serves on the Board of Directors of the American Association for Geriatric Psychiatry (AAGP) and the American Psychiatric Association (APA) Council on Geriatric Psychiatry, and has served on the editorial boards of the American Journal of Geriatric Psychiatry and the Journal of Clinical Psychiatry.
Carol Vallone is a 10 year member of the McLean Hospital board of trustees and currently chair of both the Strategy and Ventures committees. She is a seasoned education technology CEO who has launched, scaled, and sold multiple market-leading global companies that delivered online learning software and services for colleges and universities. Ms. Vallone is also a member of the board of trustees of Massachusetts General Hospital Institute of Health Professions.
Andrea Webb, PhD, is a psychophysiologist and group leader at Draper where she leads a number of efforts related to understanding and quantifying human signals. Her research focuses on the psychophysiology of mental health disorders, deception, and emotional state. She regularly publishes and presents her work in a variety of peer-reviewed venues.
Christian A. Webb, PhD, is an assistant professor of psychiatry at McLean Hospital/Harvard Medical School. He focuses his research on the investigation of the psychosocial and neurobiological mechanisms underlying symptom improvement in psychotherapeutic and pharmacological interventions for depression, with a particular focus on cognitive behavioral approaches. A clearer understanding of the “active ingredients” of treatment and mechanisms of symptom change may ultimately inform the development of more targeted—and ideally more effective and efficient—treatments. In addition, a clearer understanding of factors that cause and maintain depressive symptoms can help inform interventions aimed at treating and preventing depression. Thus, in parallel with his treatment research, Dr. Webb also conducts research focused on clarifying the etiology and underlying pathophysiology of depression.
Alik Widge, MD, PhD, is an assistant professor of psychiatry at Massachusetts General Hospital and Harvard Medical School, where he directs the Translational NeuroEngineering Lab. Dr. Widge completed his MD at the University of Pittsburgh, his PhD in robotics at Carnegie Mellon University, and his psychiatry residency at the University of Washington. His research focuses on brain stimulation for severe and treatment-resistant mental illness, with particular emphasis on deep brain stimulation and related implantable technologies. Dr. Widge’s recent work has demonstrated new algorithms for closed-loop brain stimulation and stimulation methods for modifying connectivity in the distributed circuits of mental illness. His laboratory studies rodent models for prototyping these new technologies and human patients to identify biomarkers and targets for future intervention. He also leads or co-leads programs to design new neurostimulation technologies in the central and peripheral nervous systems, to evaluate technologies for safety and efficacy in humans, and to improve the quality of clinical biomarker research nationwide.
Back to the Technology in Psychiatry Summit